Gaviscon
 

BIBLIOGRAFIA DEL SITO

Omeprazole in infants with cimetidine-resistant peptic esophagitis.

Authors
Alliet P. Raes M. Bruneel E. Gillis P.

Source
Journal of Pediatrics. 132(2):352-4, 1998 Feb.

Abstract
Twelve neurologically normal infants (age 2.9+/-0.9 months) with peptic esophagitis (grade 2) who did not respond to cimetidine (in addition to positioning, cisapride, and Gaviscon) were treated with omeprazole, 0.5 mg/kg once a day, for 6 weeks.

The effectiveness of omeprazole was evaluated in all infants by clinical assessment and endoscopy before and after treatment and by 24-hour gastric pH monitoring during treatment in seven infants.

Omeprazole therapy led to a marked decrease in symptoms, endoscopic and histologic signs of esophagitis, and intragastric acidity.


Gaviscon Advance il reflusso GE schema della diagnosi La malattia da reflusso gastroesofageo (MRGE) il principio attivo: l'alginato gli alginati farmacocinetica e tossicologia meccanismo d'azione efficacia antireflusso rispetto del ph gastrico la barriera antireflusso ricerche e studi richiedi informazioni
Novartis Italia